RepliCel Life Sciences
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-3.62-2.87-1.76-1.30-2.92-2.04-3.92-1.83-4.31-12.35N/A-2.48
Price/Sales ratio
N/AN/AN/AN/A66.7617.3717.5321.129.0710.88N/A42.07
Price/Book Value ratio
10.42-24.106.26-24.51-17.76-1.38-1.22-1.09-0.54-0.84N/A-9.57
Price/Cash Flow ratio
-4.23-3.32-2.13-1.45-20.94-2.20-8.10-2.97-2.27-2.72N/A-11.57
Price/Free Cash Flow ratio
-4.22-3.32-2.13-1.45-20.94-2.20-8.10-2.97-2.27-2.72N/A-11.57
Price/Earnings Growth ratio
-0.000.220.040.030.040.260.07-0.010.050.16N/A0.15
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/A100%100%100%100%100%100%N/A100%
Operating Profit Margin
N/AN/AN/AN/A-2237.13%-814.96%-323.51%-896.67%-54.11%-391.89%N/A-1526.04%
Pretax Profit Margin
N/AN/AN/AN/A-2286.34%-849.26%-446.74%-1151.51%-210.10%-88.12%N/A-1567.80%
Net Profit Margin
N/AN/AN/AN/A-2286.34%-849.26%-446.74%-1151.51%-210.10%-88.12%N/A-1567.80%
Effective Tax Rate
0.23%0.05%0.38%-0.37%-1.07%-1.46%-11.61%21.30%-162.52%N/AN/A-1.27%
Return on Assets
-242.77%-1212.73%-233.63%-710.89%-85.79%-594.33%-375.39%-688.29%-93.11%-108.32%N/A-340.06%
Return On Equity
-287.80%838.18%-354.03%1879.49%608.34%67.87%31.22%59.53%12.56%6.88%N/A338.11%
Return on Capital Employed
-287.90%838.66%-355.39%1872.49%-159.64%275.83%62.94%293.17%15.02%90.33%N/A58.09%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Quick Ratio
6.380.382.910.711.640.150.080.230.300.08N/A0.89
Cash ratio
1.610.170.090.421.580.010.010.130.190.03N/A0.79
Days of Sales Outstanding
N/AN/AN/AN/A255.7953.5565.6463.1984.7836.50N/A154.67
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/A0.881.411.090.913.03N/A0.44
Debt Equity Ratio
N/AN/AN/AN/AN/A-0.10-0.11-0.09-0.12-0.19N/A-0.05
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/A-0.00-0.00-0.00-0.01N/AN/A
Total Debt to Capitalization
N/AN/AN/AN/AN/A-0.11-0.13-0.10-0.14-0.23N/A-0.05
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/A-6.19-1.28-3.89-1.93-1.61N/A-3.09
Company Equity Multiplier
1.18-0.691.51-2.64-7.09-0.11-0.08-0.08-0.13-0.06N/A-3.60
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/A-3.18-7.86-2.16-7.10-3.98-3.99N/A-5.52
Free Cash Flow / Operating Cash Flow Ratio
1.001.0011111110.99N/A1
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/A-6.19-1.28-3.89-1.93-1.61N/A-3.09
Short Term Coverage Ratio
N/AN/AN/AN/AN/A-6.19-1.35-4.11-2.04-1.73N/A-3.09
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A